London, UK
Wed 02 10:15
OC1.1
Defects in QSOX2, a novel regulator of STAT5B nuclear import and transcriptional activity, lead to severe post-natal growth restriction
London, UK
Cardiff, UK
Fri 04 11:40
OC9.2
Audit of Management of Diabetic Ketoacidosis in Children at the Noah's Ark Children's Hospital for Wales
Cardiff, UK
Cardiff, UK
Birmingham, UK
Thu 03 10:00
OC5.6
Prevalence of overweight and obesity in children with bone fragility and its correlation with disease severity and fracture rate
Birmingham, UK
Alder Hey Children's Hospital, Liverpool, UK
Thu 03 12:28
OC6.4
A Collaborative Community based Approach in providing Support for Children and Young People with Severe Obesity
Alder Hey Children's Hospital, Liverpool, UK
London, UK
Fri 04 11:50
OC9.3
Diabetes and obesity in Down Syndrome across the lifespan: a retrospective cohort study using UK electronic health records
London, UK
Birmingham, UK
Fri 04 11:30
OC9.1
Access and use of new technologies in diabetes care in patients that need an Interpreter compared to those that do not
Birmingham, UK
Bristol, UK
Thu 03 16:14
OC8.5
Dublin, Republic of Ireland
Thu 03 09:40
Belfast, Northern Ireland
Thu 03 09:50
‘Proving Causation?’: antibody studies in Covid related Diabetes
Belfast, Northern Ireland
Oxford, UK
Thu 03 10:15
'What does all this mean?’ A panel discussion and Q&A session including Dr. Colin Dayan and chaired by Dr.Rachel Besser
Oxford, UK
London, UK
Thu 03 12:16
OC7.2
Self-collection of capillary blood samples at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitus
London, UK
London, UK
London, UK
London, UK
Southampton, UK
Fri 04 11:40
OC10.2
Patient and parent experiences with oral hydrocortisone formulations for adrenal insufficiency
Southampton, UK
London, UK
Bristol, UK
Wed 02 10:00
OC1.2
A rare case of short stature with high total Insulin Like Growth Factor 1 (IGF-1) and a novel pregnancy-associated plasma protein A2 (PAPPA2) gene mutation
Bristol, UK
Newcastle, UK
Thu 03 11:40
Glasgow, UK
Fri 04 12:30
Bone health in Type 1 Diabetes: The Key Determinants of Skeletal Fragility and the Role of Metformin
Glasgow, UK
London, UK
Wed 02 12:15
OC2.2
Thu 03 16:02
OC8.3
Characterisation of the first heterozygous missense HMGA2 variant helps delineate the crucial functional roles of a novel growth gene
London, UK
Bristol, UK
Wed 02 13:30
Bristol, UK
Belfast, Northern Ireland
Fri 04 10:30
Developing an early stage treatment for diabetic retinopathy
Belfast, Northern Ireland
London, UK
Fri 04 09:30
CAH & Adolescent gynaecology – an MDT perspective
London, UK
London, UK
London, UK
Cardiff, Wales
Thu 03 15:10
Birmingham, UK
Thu 03 12:34
OC7.3
Hypogonadism and pubertal disorders in Wolfram Syndrome
Birmingham, UK
Liverpool, UK
Thu 03 10:10
OC5.7
Salivary Cortisol and Cortisone in Healthy Children and Young People
Liverpool, UK
London, UK
Fri 04 12:10
OC9.5
Raising Awareness of the Importance of Preconception Counselling in Young People with Diabetes
London, UK
London, UK
Exeter, UK
Dublin, Republic of Ireland
Fri 04 09:30
London, UK
Thu 03 14:40
BSPED consensus guidelines: Emergency and peri-operative management of adrenal insufficiency in children and young people
Leeds, United Kingdom
London, UK
London, UK
Thu 03 12:16
OC7.2
Self-collection of capillary blood samples at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitus
London, UK
London, UK
London, UK
London, UK
Sheffield, UK
Thu 03 12:10
OC7.1
Comparison of outcomes of the hybrid closed loop therapy with the conventional insulin pump in the first year after pump initiation
Sheffield, UK
London, UK
Fri 04 12:10
OC9.5
Raising Awareness of the Importance of Preconception Counselling in Young People with Diabetes
London, UK
London, UK
Parent
Fri 04 10:30
CAH and adolescence - a parent's perspective
Parent
Bristol, UK
Wed 02 14:45
OC3.1
A rare form of ovotesticular difference of sex development (DSD) in combination with severe early-onset obesity due to MC4R mutation: Clinical features and diagnostic challenges
Bristol, UK
Thu 03 12:22
OC7.5
Monogenic obesity is probably not so rare - experience from a large tier 3 paediatric weight management service
Bristol, UK
Fri 04 12:30
OC9.7
Liraglutide for the treatment of severe obesity in children: early experiences from a tier 3 paediatric weight management service
Bristol, UK
Dublin, Republic of Ireland
Fri 04 14:15
Immune dysregulation driving future risk of disease in children with obesity
Dublin, Republic of Ireland
London, UK
Thu 03 09:30
OC5.3
UK Protocol for Induction of Puberty with Gonadotropins in Males with Hypogonadotropic Hypogonadism
London, UK
Maidstone, UK
Thu 03 09:10
London, UK
Thu 03 15:56
OC8.2
Endocrine Effects of MEK and BRAF Inhibitor Therapy in Paediatric Patients: A Tertiary Centre Experience
London, UK
Brimingham, UK
Thu 03 15:50
OC8.1
Do we need earlier thyroid surveillance amongst PTEN patients in the UK?
Brimingham, UK
London, UK
Birmingham, UK
Fri 04 15:15
Paediatric Endocrinology in Art
Birmingham, UK
London, UK
Thu 03 09:20
OC5.2
Central Delayed puberty in Adolescence: Differentiating the phenotypes of Congenital Hypogonadotropic Hypogonadism and Self-Limited Delayed Puberty.
London, UK
London, UK
Thu 03 10:20
OC5.8
SGPL1 deficiency impairs Leydig cell steroidogenesis and should be considered in 46XY individuals with DSD and adrenal insufficiency
London, UK
London, UK
Thu 03 12:22
OC6.3
Use of 24 weekly Decapeptyl SR in Central Precocious Puberty is Well-Tolerated and Efficacious – A Two Centre Study
London, UK
Newcastle, UK
Thu 03 09:10
OC5.1
Can lymphocyte subsets and B cell cytokines predict clinical response to Rituximab in paediatric Graves’ disease?
Newcastle, UK
Dublin, Ireland
Fri 04 11:50
OC10.4
Increasing Patient Adherence and reducing Drug Wastage: impact of a Personalised Patient Support Programme integrated with a digital connect ecosystem
Dublin, Ireland
London, UK
Fri 04 09:30
CAH & Adolescent gynaecology – an MDT perspective
London, UK
London, UK
London, UK
Southampton, UK
Wed 02 12:00
OC2.1
Coeliac disease presenting with anti-OPG antibody mediated childhood osteoporosis and response to bisphosphonate therapy
Southampton, UK
London, UK
Thu 03 12:16
OC7.2
Self-collection of capillary blood samples at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitus
London, UK
London, UK
London, UK
London, UK
Manchester, UK
Fri 04 12:20
OC9.6
A review of patient outcomes and responses to weight management strategies used by Complications from Excess Weight service, a new paediatric, hospital-based weight management service
Manchester, UK
Glasgow, UK
Fri 04 11:30
OC10.1
Hormone Replacement Therapy in Paediatric Turner Syndrome – Evaluation of Current Practice in a Dedicated Paediatric Turner Clinic and Subsequent Development of Patient Resources
Glasgow, UK
London, UK
Thu 03 09:50
OC5.5
The lack of genotype:phenotype correlations in rare causes of primary adrenal insufficiency highlights the need for genetic testing
London, UK
Belfast, UK
Dublin, Republic of Ireland
Fri 04 14:15
Belfast, Northern Ireland
Thu 03 16:20
Structured education programme for Type 1 Diabetes in Northern Ireland
Belfast, Northern Ireland
Belfast, Northern Ireland
Belfast, Northern Ireland
Wed 02 16:15
OC4.2
Treatment-induced neuropathy of diabetes: A case report
Belfast, Northern Ireland
Belfast, Northern Ireland
Thu 03 16:20
Structured education programme for Type 1 Diabetes in Northern Ireland
Belfast, Northern Ireland
Belfast, Northern Ireland
Southampton, UK
Thu 03 12:10
OC6.1
Pubertal staging examinations: A national survey of current practice in consent and chaperone use
Southampton, UK
Manchester, UK
Leeds, United Kingdom
Thu 03 14:40
BSPED consensus guidelines: Emergency and peri-operative management of adrenal insufficiency in children and young people
Leeds, United Kingdom
London, UK
Birmingham, UK
London, UK
Thu 03 12:28
OC7.4
Type A insulin resistance syndrome presenting with PCOS features and an unusual pattern of diabetes in a 10-year-old female
London, UK
Dublin, Republic of Ireland
Thu 03 11:40
Manchester, UK
Manchester, UK
Thu 03 12:34
OC6.5
Bone Mineralisation as Assessed by Bone Health Index in Children with Congenital Adrenal Hyperplasia
Manchester, UK
Manchester, UK
Birmingham, UK
Fri 04 12:00
OC9.4
Do the UK’s commercially available real-time continuous glucose monitoring devices have robust accuracy data for paediatrics?
Birmingham, UK
Fri 04 12:40
OC9.8
Cyclic improvement of a structured education programme teaching dynamic glucose management strategies in children and young people with type 1 diabetes using Continuous Glucose Monitoring
Birmingham, UK
Fri 04 15:15
How to create and adapt exercise plans when using Continuous Glucose Monitoring (CGM) and Automated Insulin Delivery Systems (AID) with type 1 diabetes
Birmingham, UK
Manchester, UK
Thu 03 09:40
OC5.4
Greater Postnatal Adiposity Gain Following Inadequate Fetal Growth in The Manchester BabyGRO Study
Manchester, UK
Thu 03 12:16
OC6.2
The Arginine-nitric-oxide Pathway Links Suboptimal Fetal Growth to Higher Childhood Systolic Blood Pressure in The Manchester BabyGRO Study
Manchester, UK
London, UK
Thu 03 09:20
‘DIMPLES’: Children presenting with diabetes and diabetic ketoacidosis to Emergency Departments during the COVID-19 pandemic in the UK and Ireland: a multicentre retrospective observational study
London, UK
Dublin, Republic of Ireland
Leeds, UK
Fri 04 14:45
Non-alcoholic fatty liver disease
Leeds, UK
Liverpool, UK
Thu 03 10:30
OC5.9
Nottingham, UK
Fri 04 14:45
Manchester, UK
Thu 03 12:34
OC6.5
Bone Mineralisation as Assessed by Bone Health Index in Children with Congenital Adrenal Hyperplasia
Manchester, UK
Manchester, UK
Dublin, Republic of Ireland
Thu 03 11:10
Impact of Diabetes Ketoacidosis on glycaemic control
Dublin, Republic of Ireland
UK
London, UK
Thu 03 12:16
OC7.2
Self-collection of capillary blood samples at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitus
London, UK
London, UK
London, UK
London, UK
Glasgow, UK
Wed 02 15:30
Thu 03 15:10
London, UK
Wed 02 14:30
OC3.2
Two cases on the Carney Complex spectrum secondary to PRKACA/PRKAR1A variants presenting with Cushing Syndrome in childhood
London, UK
Cardiff, UK
Fri 04 11:40
OC9.2
Audit of Management of Diabetic Ketoacidosis in Children at the Noah's Ark Children's Hospital for Wales
Cardiff, UK
Cardiff, UK
London, UK
London, UK
Fri 04 12:20
OC10.3
Development and testing of a novel ‘GrowthMonitor’ Smartphone App for growth monitoring and the detection of growth disorders
London, UK
Thu 03 10:00
OC5.6
Prevalence of overweight and obesity in children with bone fragility and its correlation with disease severity and fracture rate
Birmingham, UK
Cardiff, UK
Fri 04 12:10
OC10.6
A comparative study observing the association between Graves’ disease and the Covid-19 pandemic in children
Cardiff, UK
Cambridge, UK
London, UK
Fri 04 09:30
CAH & Adolescent gynaecology – an MDT perspective
London, UK
London, UK
London, UK
Glasgow, UK
Thu 03 16:08
OC8.4
A national survey of bone-endocrine monitoring in Duchenne muscular dystrophy and the patients’ experience
Glasgow, UK
Cambridge, UK
Fri 04 12:00
OC10.5
Factors affecting the hypoglycaemic response in the Insulin Tolerance Test in paediatric patients
Cambridge, UK
Workshop
1
Oral
10
Expert
3
Plenary
11
Catering and Social
11
Nurse
1
Other
8
Symposium
6
No Session Type
0
Wed 02 10:15
OC1.1
Defects in QSOX2, a novel regulator of STAT5B nuclear import and transcriptional activity, lead to severe post-natal growth restriction
London, UK
Wed 02 10:00
OC1.2
A rare case of short stature with high total Insulin Like Growth Factor 1 (IGF-1) and a novel pregnancy-associated plasma protein A2 (PAPPA2) gene mutation
Bristol, UK
Wed 02 12:00
OC2.1
Coeliac disease presenting with anti-OPG antibody mediated childhood osteoporosis and response to bisphosphonate therapy
Southampton, UK
Wed 02 12:15
OC2.2
Wed 02 14:30
OC3.2
Two cases on the Carney Complex spectrum secondary to PRKACA/PRKAR1A variants presenting with Cushing Syndrome in childhood
London, UK
Wed 02 14:45
OC3.1
A rare form of ovotesticular difference of sex development (DSD) in combination with severe early-onset obesity due to MC4R mutation: Clinical features and diagnostic challenges
Bristol, UK
Wed 02 16:15
OC4.2
Treatment-induced neuropathy of diabetes: A case report
Belfast, Northern Ireland
Thu 03 09:10
OC5.1
Can lymphocyte subsets and B cell cytokines predict clinical response to Rituximab in paediatric Graves’ disease?
Newcastle, UK
Thu 03 09:20
OC5.2
Central Delayed puberty in Adolescence: Differentiating the phenotypes of Congenital Hypogonadotropic Hypogonadism and Self-Limited Delayed Puberty.
London, UK
Thu 03 09:30
OC5.3
UK Protocol for Induction of Puberty with Gonadotropins in Males with Hypogonadotropic Hypogonadism
London, UK
Thu 03 09:40
OC5.4
Greater Postnatal Adiposity Gain Following Inadequate Fetal Growth in The Manchester BabyGRO Study
Manchester, UK
Thu 03 09:50
OC5.5
The lack of genotype:phenotype correlations in rare causes of primary adrenal insufficiency highlights the need for genetic testing
London, UK
Thu 03 10:00
OC5.6
Prevalence of overweight and obesity in children with bone fragility and its correlation with disease severity and fracture rate
Birmingham, UK
Thu 03 10:10
OC5.7
Salivary Cortisol and Cortisone in Healthy Children and Young People
Liverpool, UK
Thu 03 10:20
OC5.8
SGPL1 deficiency impairs Leydig cell steroidogenesis and should be considered in 46XY individuals with DSD and adrenal insufficiency
London, UK
Thu 03 10:30
OC5.9
Thu 03 12:10
OC6.1
Pubertal staging examinations: A national survey of current practice in consent and chaperone use
Southampton, UK
Thu 03 12:16
OC6.2
The Arginine-nitric-oxide Pathway Links Suboptimal Fetal Growth to Higher Childhood Systolic Blood Pressure in The Manchester BabyGRO Study
Manchester, UK
Thu 03 12:22
OC6.3
Use of 24 weekly Decapeptyl SR in Central Precocious Puberty is Well-Tolerated and Efficacious – A Two Centre Study
London, UK
Thu 03 12:28
OC6.4
A Collaborative Community based Approach in providing Support for Children and Young People with Severe Obesity
Alder Hey Children's Hospital, Liverpool, UK
Thu 03 12:34
OC6.5
Bone Mineralisation as Assessed by Bone Health Index in Children with Congenital Adrenal Hyperplasia
Manchester, UK
Manchester, UK
Thu 03 12:10
OC7.1
Comparison of outcomes of the hybrid closed loop therapy with the conventional insulin pump in the first year after pump initiation
Sheffield, UK
Thu 03 12:16
OC7.2
Self-collection of capillary blood samples at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitus
London, UK
London, UK
London, UK
London, UK
Thu 03 12:22
OC7.5
Monogenic obesity is probably not so rare - experience from a large tier 3 paediatric weight management service
Bristol, UK
Thu 03 12:28
OC7.4
Type A insulin resistance syndrome presenting with PCOS features and an unusual pattern of diabetes in a 10-year-old female
London, UK
Thu 03 12:34
OC7.3
Hypogonadism and pubertal disorders in Wolfram Syndrome
Birmingham, UK
Thu 03 15:50
OC8.1
Do we need earlier thyroid surveillance amongst PTEN patients in the UK?
Brimingham, UK
Thu 03 15:56
OC8.2
Endocrine Effects of MEK and BRAF Inhibitor Therapy in Paediatric Patients: A Tertiary Centre Experience
London, UK
Thu 03 16:02
OC8.3
Characterisation of the first heterozygous missense HMGA2 variant helps delineate the crucial functional roles of a novel growth gene
London, UK
Thu 03 16:08
OC8.4
A national survey of bone-endocrine monitoring in Duchenne muscular dystrophy and the patients’ experience
Glasgow, UK
Thu 03 16:14
OC8.5
Fri 04 11:30
OC9.1
Access and use of new technologies in diabetes care in patients that need an Interpreter compared to those that do not
Birmingham, UK
Fri 04 11:40
OC9.2
Audit of Management of Diabetic Ketoacidosis in Children at the Noah's Ark Children's Hospital for Wales
Cardiff, UK
Cardiff, UK
Fri 04 11:50
OC9.3
Diabetes and obesity in Down Syndrome across the lifespan: a retrospective cohort study using UK electronic health records
London, UK
Fri 04 12:00
OC9.4
Do the UK’s commercially available real-time continuous glucose monitoring devices have robust accuracy data for paediatrics?
Birmingham, UK
Fri 04 12:10
OC9.5
Raising Awareness of the Importance of Preconception Counselling in Young People with Diabetes
London, UK
London, UK
Fri 04 12:20
OC9.6
A review of patient outcomes and responses to weight management strategies used by Complications from Excess Weight service, a new paediatric, hospital-based weight management service
Manchester, UK
Fri 04 12:30
OC9.7
Liraglutide for the treatment of severe obesity in children: early experiences from a tier 3 paediatric weight management service
Bristol, UK
Fri 04 12:40
OC9.8
Cyclic improvement of a structured education programme teaching dynamic glucose management strategies in children and young people with type 1 diabetes using Continuous Glucose Monitoring
Birmingham, UK
Fri 04 11:30
OC10.1
Hormone Replacement Therapy in Paediatric Turner Syndrome – Evaluation of Current Practice in a Dedicated Paediatric Turner Clinic and Subsequent Development of Patient Resources
Glasgow, UK
Fri 04 11:40
OC10.2
Patient and parent experiences with oral hydrocortisone formulations for adrenal insufficiency
Southampton, UK
Fri 04 11:50
OC10.4
Increasing Patient Adherence and reducing Drug Wastage: impact of a Personalised Patient Support Programme integrated with a digital connect ecosystem
Dublin, Ireland
Fri 04 12:00
OC10.5
Factors affecting the hypoglycaemic response in the Insulin Tolerance Test in paediatric patients
Cambridge, UK
Fri 04 12:10
OC10.6
A comparative study observing the association between Graves’ disease and the Covid-19 pandemic in children
Cardiff, UK
Fri 04 12:20
OC10.3
Development and testing of a novel ‘GrowthMonitor’ Smartphone App for growth monitoring and the detection of growth disorders
London, UK
Wed 02 13:30
Wed 02 15:30
Thu 03 09:10
Thu 03 09:20
‘DIMPLES’: Children presenting with diabetes and diabetic ketoacidosis to Emergency Departments during the COVID-19 pandemic in the UK and Ireland: a multicentre retrospective observational study
London, UK
Thu 03 09:40
Thu 03 09:50
‘Proving Causation?’: antibody studies in Covid related Diabetes
Belfast, Northern Ireland
Thu 03 10:15
'What does all this mean?’ A panel discussion and Q&A session including Dr. Colin Dayan and chaired by Dr.Rachel Besser
Oxford, UK
Thu 03 11:10
Impact of Diabetes Ketoacidosis on glycaemic control
Dublin, Republic of Ireland
Thu 03 11:40
Thu 03 15:10
Thu 03 14:40
BSPED consensus guidelines: Emergency and peri-operative management of adrenal insufficiency in children and young people
Leeds, United Kingdom
London, UK
Thu 03 15:10
Fri 04 09:30
CAH & Adolescent gynaecology – an MDT perspective
London, UK
London, UK
London, UK
Fri 04 10:30
CAH and adolescence - a parent's perspective
Parent
Fri 04 14:15
Immune dysregulation driving future risk of disease in children with obesity
Dublin, Republic of Ireland
Fri 04 14:45
Non-alcoholic fatty liver disease
Leeds, UK
Fri 04 15:15
Paediatric Endocrinology in Art
Birmingham, UK
Thu 03 16:20
Structured education programme for Type 1 Diabetes in Northern Ireland
Belfast, Northern Ireland
Belfast, Northern Ireland
Fri 04 12:30
Bone health in Type 1 Diabetes: The Key Determinants of Skeletal Fragility and the Role of Metformin
Glasgow, UK
Thu 03 11:40
Fri 04 09:30
Fri 04 10:30
Developing an early stage treatment for diabetic retinopathy
Belfast, Northern Ireland
Fri 04 14:15
Fri 04 14:45
Fri 04 15:15
How to create and adapt exercise plans when using Continuous Glucose Monitoring (CGM) and Automated Insulin Delivery Systems (AID) with type 1 diabetes
Birmingham, UK
0 result(s) found.